VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PAVM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PAVMPAVmed Inc.
$5.36$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPAVMBalance Sheet

PAVmed Inc. (PAVM) Balance Sheet

12Y historyFree accessUpdated daily

Financial stability is severely compromised, with cash reserves plummeting to $1.5 million as of 2025Q4 against a total debt burden of $13.3 million.

PAVM Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Total Current Assets7.41M2.56M2.16M24.5M43.93M82.64M18.94M6.55M8.46M1.62M741.17K776.03K842.08K
Cash & Short-Term Investments6.46M1.54M1.19M19.64M42.75M79.25M17.52M6.22M8.22M1.54M585.68K767.27K839.08K
Cash Only6.46M1.54M1.19M19.64M39.74M77.26M17.26M6.22M8.22M1.54M585.68K767.27K839.08K
Short-Term Investments00003M1.99M262K000000
Accounts Receivable21K15K18K61K17K200K0000000
Days Sales Outstanding0.1777.112.199.0816.46146-------
Inventory0239K266K539K261K526K855K000000
Days Inventory Outstanding0.24270.0816.0830.6426.36328.19-------
Other Current Assets615K003.41M599K808K507K34.12K00155.49K8.76K0
Total Non-Current Assets38M36.26M28.5M8.62M10.05M4.34M837K692.94K36.27K16.19K129.25K438.06K0
Property, Plant & Equipment1.95M2.08M2.65M6.05M5.49M1.58M82K036.27K16.19K18K00
Fixed Asset Turnover10.26x0.03x1.13x0.41x0.07x0.32x-------
Goodwill0000000000000
Intangible Assets0001.42M3.44M2.03M0000000
Long-Term Investments137.73M34.12M25.64M0000000000
Other Non-Current Assets56K56K208K1.15M1.12M725K755K692.94K00111.25K438.06K0
Total Assets45.42M38.81M30.66M33.12M53.98M86.98M19.78M7.24M8.5M1.64M870.42K1.21M842.08K
Asset Turnover0.53x0.00x0.10x0.07x0.01x0.01x-------
Asset Growth %48.55%26.59%-7.42%-38.65%-37.94%339.76%173.16%-14.78%418.18%88.38%-28.31%44.18%-
Total Current Liabilities3.66M14.84M35.45M54.18M41.2M7.56M20.25M11.88M10.97M2.54M1.19M580.17K47.25K
Accounts Payable983K678K657K1.79M2.7M3.3M2.97M2.35M1.74M864.4K949.41K165.32K14.75K
Days Payables Outstanding2.24766.1639.72101.54273.092.06K-60.37K64.83K44.38K91.36K--
Short-Term Debt588K11.1M29.1M44.2M33.65M014.96M8.14M7.9M0000
Deferred Revenue (Current)00656.34M0000000000
Other Current Liabilities2.09M1.97M-654.83M4.12M10K25K355K311.63K272.43K983.6K08.39K0
Current Ratio2.02x0.17x0.06x0.45x1.07x10.93x0.94x0.55x0.77x0.64x0.62x1.34x17.82x
Quick Ratio2.02x0.16x0.05x0.44x1.06x10.86x0.89x0.55x0.77x0.64x0.62x1.34x17.82x
Cash Conversion Cycle-1.83-418.97-21.44-61.82-230.27-1.58K-------
Total Non-Current Liabilities16.77M1.68M2.25M2.96M1.85M0010.49M9.64M1.94M949.41K165.32K0
Long-Term Debt14.9M000000001.94M000
Capital Lease Obligations6.99M1.68M2.25M2.96M1.85M00000000
Deferred Tax Liabilities0000000000000
Other Non-Current Liabilities345K000000000000
Total Liabilities20.43M16.51M37.69M57.14M43.05M7.56M20.25M11.88M10.97M4.49M1.19M580.17K47.25K
Total Debt17.01M13.35M31.86M48.73M36.64M014.96M8.14M7.9M1.94M000
Net Debt10.55M11.81M30.68M29.09M-3.11M-77.26M-2.3M1.92M-319.12K409.25K-585.68K-767.27K-839.08K
Debt / Equity0.68x0.60x--3.35x--------
Debt / EBITDA-0.00x------------
Net Debt / EBITDA-0.00x------------
Interest Coverage-403006.30x-1038.38x632.71x-133.57x-79.59x--440.58x-510.77x-6.34x-12.14x---
Total Equity24.99M22.3M-7.03M-24.02M10.93M79.42M-473K-4.64M-2.48M-2.85M-319.07K633.92K794.83K
Equity Growth %1021.37%417.08%70.72%-319.66%-86.23%16890.27%89.8%-87.31%13.07%-792.71%-150.33%-20.24%-
Book Value per Share1580.8233.26-3.23-99.6455.24461.04-4.49-69.12-50.02-94.97-11.0721.4326.59
Total Shareholders' Equity39.52M33.97M-2.5M-53.83M-9.68M61.67M1.9M-3.82M-2.31M-2.85M-319.07K633.92K794.83K
Common Stock6K1K11K9K6K86K64K40.48K27.14K14.55K13.33K12.25K10.86K
Retained Earnings-259.03M-258.73M-254.97M-294.43M-228.17M-138.91M-88.28M-53.71M-36.99M-17.91M-7.7M-2.05M-274.38K
Treasury Stock0000-408K00000000
Accumulated OCI00000000-2.03M-1.03M000
Minority Interest-14.54M-11.67M-4.54M29.81M20.61M17.75M-2.37M-814.28K-161.51K0000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Immediate liquidity and insolvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Critical Cash Runway Nears Exhaustion

According to the most recent quarterly data, PAVM's cash and equivalents have plummeted to $1.5 million as of 2025Q4, representing a severe liquidity contraction that leaves the company with a dangerously thin buffer against its ongoing operating losses and high fixed-cost structure.

The current ratio of 0.17 in 2025Q4 highlights a profound inability to meet short-term obligations, suggesting that the firm is likely reliant on external financing to maintain basic operations. Investors should monitor the company's ability to secure additional capital, as the current cash position appears insufficient to support the business for more than a very limited period.

Leverage Burden Amidst Revenue Collapse

As reported in financial statements, the company's total debt reached $13.3 million in 2025Q4, creating a precarious leverage profile where debt obligations significantly outweigh the firm's current cash reserves and negligible revenue-generating capacity.

The debt-to-equity ratio of 0.60 indicates that the company is increasingly reliant on debt financing to bridge the gap between its high burn rate and lack of commercial success. This leverage structure appears unsustainable, and the firm may face significant challenges in refinancing these obligations without further dilutive equity issuance or restructuring.

Balance Sheet Erosion Signals Distress

Based on the ten-quarter trend, PAVM's balance sheet has undergone a significant deterioration, with total assets declining from $45.4 million in 2026Q1 to $38.8 million in 2025Q4, reflecting a consistent erosion of the firm's underlying resource base.

The persistent accumulation of negative retained earnings, which reached -$258.7 million in 2025Q4, underscores a long-term pattern of value destruction that has effectively hollowed out the company's equity base. This trajectory suggests that the business model has failed to achieve the necessary scale to stabilize its financial position, leaving the balance sheet in a highly vulnerable state.

Accounting Distortions Mask Operational Reality

Analysis of the provided figures suggests that the company's equity position is heavily influenced by non-operating accounting adjustments, as evidenced by the volatile swings in net assets that do not correlate with the firm's actual commercial performance or cash flow generation.

The historical shift from negative equity in 2024 to positive equity in 2025 appears to be driven by accounting maneuvers rather than organic growth, which warrants caution for investors evaluating the firm's true net worth. This discrepancy implies that the headline equity figures may significantly overstate the company's tangible value and resilience in the face of ongoing operational distress.

PAVM — Frequently Asked Questions

Quick answers to the most common questions about buying PAVM stock.

What are the total assets of PAVmed Inc. (PAVM)?

As of 2025, PAVmed Inc. (PAVM) had total assets of $38.8M including $2.6M in current assets.

How much debt does PAVmed Inc. (PAVM) have?

PAVmed Inc. (PAVM) carries total debt of $13.3M, offset by $1.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of PAVmed Inc.?

PAVmed Inc. (PAVM) has total shareholders' equity (book value) of $34.0M ($33.26 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is PAVmed Inc.'s current ratio and liquidity?

PAVmed Inc. (PAVM) reported a current ratio of 0.17x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.